Nalaganje...
Microtubule inhibitor-based antibody–drug conjugates for cancer therapy
The specificity of monoclonal antibodies represents a potential therapeutic advantage, but their use as single agents in oncology has proven limited to date. The development of antibody-drug conjugates (ADCs) takes advantage of the specificity of the monoclonal antibody and potent cytotoxic effect o...
Shranjeno v:
| izdano v: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4259504/ https://ncbi.nlm.nih.gov/pubmed/25506226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S46887 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|